Back to Journals » International Journal of General Medicine » Volume 4

Pleiotropic effects of the HMG-CoA reductase inhibitors

Authors Mihos C, Santana O

Published 4 April 2011 Volume 2011:4 Pages 261—271

DOI https://doi.org/10.2147/IJGM.S16779

Review by Single anonymous peer review

Peer reviewer comments 3



Christos G Mihos, Orlando Santana
Columbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL, USA

Abstract: The HMG-CoA reductase inhibitors (statins) are used extensively in the treatment of hyperlipidemia. They have also demonstrated a benefit in a variety of other disease processes. These secondary actions are known as pleiotropic effects. Our paper serves as a focused and updated discussion on the pleiotropy of statins and emphasizes the importance of randomized placebo-controlled trials to further elucidate this interesting phenomenon.

Keywords: HMG-CoA inhibitors, pleiotropic, reductase, review, statins

Creative Commons License © 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.